Elekta International
Elekta Australia
Elekta Canada
Elekta China
Elekta Hong Kong
Elekta India
Elekta Japan
Elekta New Zealand
Elekta Singapore
Elekta United States
Elekta Investigator Initiated Research Grant Application
Introduction
Elekta has a long and rich tradition of supporting investigator initiated research that leads to advances in technology and clinical care. We depend on close collaborative relationships with investigators who are themselves leaders in their respective fields. These relationships and the results of our joint research efforts are among the keys to our success and leadership in our industry.
In order to assure that we maintain the highest standards, we have formulated a process that helps guide applicants through the research application. This process is intended to result in a well-defined and high quality research program.
Elekta’s Research Collaborations Program complies with international and US federal regulations that govern research funding provided by health care manufacturers to health care providers. The Program complies with the Elekta Code of Conduct, Medical Imaging and Technology Alliance (MITA) Code of Ethics on Interactions with Healthcare Professionals and the Compliance Program Guidance for Pharmaceutical Manufacturers from the US Office of Inspector General.
Elekta can support investigator initiated Research and Development Agreement Projects via a number of mechanisms that include the provision of research funds, information, access to research hardware and/or software, and access to other Elekta resources. In exchange, Elekta expects to benefit in the form of information, access to intellectual property, research results… etc. that are products of your work.
To apply for a research grant, you will need to complete the attached application. This actual application has been adapted from and scaled down from U.S. National Institution of Health applications that are likely familiar to you, and it should be relatively easy to complete. Please note that Elekta places a high value on having clearly defined goals and tasks, meeting specific milestones and providing associated deliverables. It should be made clear how these will be met and achieved.
Applicants should limit their requests to only that which is required to complete the project. Applications should be focused, achievable and not overly ambitious.
Elekta’s research committee meets on a regular basis to review grant applications. We commit ourselves to respond to you within 8-12 weeks of receipt of a completed application form. If approved, we will work with you to develop a formal Technical Research Agreement. The project only begins after the Agreement has been executed, and no commitments should be made by the researcher in anticipation of this event.
Indirect Costs - In an effort to optimize the balance between direct research contributions and overhead costs, Elekta has established a corporate policy to support a maximum funding level for Indirect Costs of 25%. This is consistent with, and in some cases exceeds Industry-wide policies, as well as indirect funding levels of substantially larger research support programs.
Principal investigators are required to submit semi-annual Progress Reports as well as a Final Report.
Download Elekta Research Grant Application Form
The application should be sent to:
| NORTH AMERICA Rajinder Singh Dhada, MBA Elekta Inc. | REST OF THE WORLD Kevin J Brown, CPhys FInstP Elekta Ltd |
| Tel: 770 670 2366 / 770 670 2366 Fax: 770 300 9420 Email: rajinder.dhada@elekta.com | Tel: +44 1293 654993 Fax: +44 1293 654113 E-mail: kevin.brown@elekta.com |
References:
- MITA Code of Ethics together with Frequently Asked Questions on Interactions with Healthcare Providers, follow the link http://www.medicalimaging.org
- OIG Compliance Program Guidance for Pharmaceutical Manufacturers - Federal Register / Vol. 68, No. 86 / Monday, May 5, 2003 - FROIG05052003.pdf
Web Page REVISED February 4, 2010